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Introduction 
Breast cancer is one of the most common malignancies in 
women. It continues to be a major burden and cause of death 
worldwide. In cases of early detection, it is treatable by 
surgery, radiation and chemotherapy, but the prognosis is 
influenced by many factors. The majority of cancer cells 
represent dynamic karyotypic changes, including 
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Abstract  
Breast cancer is one of the most commonly diagnosed malignancies in women around the world. Chromosomal rearrangements 
are known to play important role in the pathogenesis of many diseases including cancer. In case of breast cancer, chromosomal 
changes are detectable at all stages of tumour development providing excellent opportunity for prognosis and therapy. Present 
work aimed to study the frequency of chromosomal aberrations and satellite associations in human peripheral blood lymphocyte 
culture of freshly diagnosed breast cancer patients after in vitro exposure to combination of anticancer drug treatment. The present 
study reveals that, combination of anticancer drugs significantly increases chromosomal aberrations without altering the frequency 
of satellite associations. 
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chromosomal rearrangements [1]. A positive association 
between the frequency of chromosomal aberrations in 
peripheral blood lymphocytes (PBLs) and the risk of cancer 
at different sites has been supported by numerous clinical 
observations [2]. Different case-control studies have also 
reported a significant increase in the frequency of aberrant 
cells in PBLs of cancer patients [3-11]. However in case of 
breast cancer; chromosomal aberrations are found to be a 
dominant genetic event and may play an important role in 
cancer progression. 
In the present study, chromosomal rearrangements were 
observed in freshly diagnosed breast patients who had not 
undergone any chemotherapeutic and/or radiation treatment. 
Further, peripheral blood lymphocytes of patients were 
exposed to combination of anticancer drugs namely 5- 
Fluorouracil {5-FU}, Cyclophosphamide and Adriamycin 
commonly used for breast cancer treatment. 
5-FU causes DNA damage, specifically double strand 
(and single-strand) breaks, during S phase of cell cycle 
[12-13]. On the other hand, cyclophosphamide is a potent 
alkylating agent being cytotoxic to tumour cells via 
crosslinking of DNA strands and inhibition of protein 
synthesis [14]. Mechanism of action of adriamycin is still 
not fully understood but suggested mechanisms includes 
formation of DNA adducts, production of free radicals and 
inhibition of protein synthesis [15]. 
Therefore, it is essential to assign, role of cytogenetic 
endpoints such as chromosomal aberrations and satellite 
associations for the diagnosis and treatment of breast cancer. 
Materials and Methods 
Lymphocyte Culture 
Lymphocyte cultures were set up by Hungerford [16] with 
slight modifications [17]. Heparinized whole blood (0.5 ml) 
was added to a mixture containing 5 ml of culture medium 
RPMI 1640 and 0.1 ml phytohemagglutinin (Lectin). Then 
the culture vials were kept in HERA cell 
150
 CO2 incubator 
for 71 hrs, at 37 C with 5 % CO2. Then 0.1 ml demecolcine 
solution was added at last 2 hours of incubation period to 
arrest cells at metaphase. The cells were collected by 
centrifugation, resuspended in a prewarmed hypotonic 
solution (KCL, 0.075 M) for 20-25 minutes and fixed in 
chilled methanol/acetic acid (3:1 v/v) solution (Carnoy’s 
fixative). Then drops of cell suspension were allowed to fall 
from at least 2.5 feet height on pre chilled and chemically 
cleaned slides. These slides were air dried on a hot plate at 
50-60 C. All slides were blind coded and labelled soon after 
assuring about well spread chromosome. 
Nucleolar Organizing Regions staining by AgNO3 
Nucleolar Organizing Regions (NOR) staining was 
performed according to the silver nitrate (AgNO3) method of 
Verma and Babu [18]. AgNO3 solution was prepared by 
mixing 4 g AgNO3 in 8 ml distilled water and stored light 
protected at 4 C. Few drops of silver nitrate solution were 
applied on slide along with 2 % gelatine solution mixed with 
formic acid. Heat was applied till brownish colour appeared. 
Prepared slides were blind coded and scored for 
observations of NORs. 
Preparation of drug 
All the drugs (5-FU, adriamycin and cyclophosphamide) 
were prepared in sterile distilled water and 1 M 
concentration of stock solutions was prepared. After 
optimization of various dilutions in the present study, the 
sublethal concentrations of 5-FU (30 ng/30µl), adriamycin 
(15 ng/15µl) and cyclophosphamide (15 ng/15µl) were 
used. 
Experimental Protocol 
Total of 22 breast cancer patients (blood was collected from 
Lions Cancer Detection Centre, Surat) were studied along 
with 22 age and sex matched female controls. Written 
consent of patients was obtained.  
All blood samples collected from breast cancer patients 
were divided in two parts. 
Part A- Total 11 PBL cultures were set up without 
chemotherapeutic exposure. 
Part B- Total 11 PBL cultures of breast cancer patient 
were exposed to a combination of 5-FU {30 ng/30µl}, 
adriamycin {15 ng/15µl} and cyclophosphamide {15 
ng/15µl} added after 24 hours of initiation of lymphocyte 
culture. Cells were exposed to drugs combination for 48 
hours. 
Similarly 22 PBL cultures were prepared from healthy 
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females’ which serve as a control. 
Results were analysed using student t-test with aid of 
SPSS software. 
Results 
Results indicated frequency of chromosomal aberrations 
observed with and without chemotherapeutic exposure to 
peripheral blood lymphocytes of breast cancer patients in 
comparison to controls (Table 1). We found significant 
increase in chromosomal aberrations in breast cancer 
patients in comparison to that of control (P < 0.05).  PBLs 
of patients not exposed to any chemotherapeutic agents 
showed significant increase in chromatid gaps and 
endoreduplication as compared to controls. In addition, the 
frequency of hyperdiploid configuration was also found to 
be significantly higher in breast cancer patients (P < 0.05). 
 
 
Table 1 Frequency of chromosomal aberrations in breast cancer 
 
Groups 
 
Chromosome type aberrations Chromatid type aberrations 
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Before Chemotherapy 
Control 
(Mean) 
0.818 0.272 1.181 0.454 0.727 0.545 0.363 0.454 0.454 3.545 
 
0.636 
 
Breast cancer 
(Mean) 
0.363 0.272 0.818 0.909 1.090 1.818 0.363 2.636 1.000 5.818 1.636 
P value 0.075 0.500 0.251 0.134 0.208 0.016* 0.500 0.005* 0.211 0.146 
 
0.037* 
 
After chemotherapy 
Control 
(Mean) 
0.181 0.363 0.363 0.636 0.454 0.272 0.181 
 
0.727 
 
0.636 4.272 0.363 
Breast cancer 
(Mean) 
0.636 0.363 0.636 0.454 1.454 0.272 0.545 1.090 1.000 4.818 1.000 
P value 0.034* 0.500 0.147 0.341 0.164 0.500 0.101 0.152 0.147 0.295 
 
0.008* 
 
(* - P value < 0.05 significantly different from control)  
(B- Break, G- Gap, D- Dicentric, R-Ring, Int- Chromatid Interchange, ER- Endoreduplication, TA- Telomeric association, Hypo- Hypodiploid, Hyper- 
Hyperdiploid)  
 
Lymphocytes of patients and controls were exposed to a 
combination of 5-FU (30 ng/30µl), adriamycin (15 ng/15µl) 
and cyclophosphamide (15 ng/15µl) drugs added at 24
th
 
hours after initiation of culture, exhibited significant increase 
in frequency of chromosome breaks and hyperdiploid 
configuration (P value < 0.005) as compared to controls 
(Figure 1). 
Frequency of satellite associations of acrocentric 
chromosomes in patients and controls was studied after 
exposure to chemotherapeutic agents (Figure 1). A 
significant increase (P < 0.05) was observed in DD (between 
D group chromosomes) and DG (between D & G group 
chromosomes) associations of freshly diagnosed cancer 
patient. Whereas, SAs were not significant after exposure to 
chemotherapeutic drugs (Table 2). 
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Figure 1 Chromosomal rearrangements in breast cancer patients. (A) atellite association (DG type) in hyperdiploid metaphase. (B) 
Chromatid gap, double minutes DD and GG acrocentric associations (partial plate). (C) Chromosome break (partial plate). (D) 
NOR stained in DD type acrocentric association (partial plate). 
 
A 
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Table 2 Frequency of satellite associations in breast cancer 
 
Groups 
Type of Satellite Association 
DD DG GG DDG DGG DDD GGG 3DG/3GD DDGG 
Before chemotherapy 
Control 
(Mean) 
1.727 3.363 1.363 0.272 1.090 0.0 0.0 0.0 0.0 
Breast cancer 
(Mean) 
3.727 6.363 1.909 0.545 0.818 0.0 0.0 0.0 0.0 
P value 0.040* 0.029* 0.250 0.105 0.332 - - - - 
After chemotherapy 
Control 
(Mean) 
1.272 0.727 0.818 0.090 0.090 0.090 0.0 0.0 0.0 
Breast cancer 
(Mean) 
1.000 0.727 0.727 0.090 0.090 0.090 0.0 0.0 0.0 
P value 0.265 0.500 0.392 0.500 0.500 0.500 - - - 
          (* - Significant at p value < 0.05) 
 
Discussion 
It has been hypothesized that the frequency of chromosomal 
aberrations in peripheral blood lymphocytes of healthy 
individuals represents a marker of susceptibility to cancer 
[19-20]. Chromosomal aberrations are usually considered to 
derive from unrepaired or misrepaired DNA lesions induced 
by exogenous or endogenous exposure to DNA-damaging 
agents. A comprehensive review of genetic rearrangements 
consequent to chromosome aberrations and their role in the 
pathogenesis of solid and hematologic cancers was reported 
[21]. 
A Significant higher frequency of aberrant metaphases in 
PBLs of breast cancer patients has been well documented 
[22-23]. In addition, chromosome breaks have also been 
reported by Ochi et al. [24], in peripheral blood leucocytes of 
untreated breast cancer patients. Our results are in good 
agreement with that of Ochi et al. We report a high 
frequency of chromosome breaks in breast cancer patients. 
Mirfakhraie et al. [25] have indicated the loss of 
chromosomes 1, 3 and r (11) in PBLs of breast cancer 
patients. However we didn’t find any such change. High 
frequency of aberrations in PBLs of cancer patients may 
throw light on the defective genetic mechanisms. 
It is interesting to note that significantly higher frequency 
of hyperdiploid configuration was found in both drug treated 
as well as untreated lymphocytes of patients as compared to 
controls. The similar results have been shown by Sophia et 
al. [26], in Non-Hodgkin Lymphoma.  
There have been few reports available on frequency of 
satellite associations in healthy individuals
 
[27-31]
;
 however 
the frequency of satellite associations was mainly studied in 
various age groups [32-35]. There is a paucity of 
information on the study of satellite association with special 
reference to female cancers [1]. Therefore, an attempt was 
made to study freshly diagnosed breast cancer patients who 
had not undergone chemotherapeutic treatment. The 
comparison was made with age and sex matched female 
controls. Results revealed significant higher frequency (P < 
0.05) of SA between DD and DG group of acrocentric 
chromosomes as compared to control (Table 2). This shows 
significant involvement of D and G group chromosomes in 
the pathogenesis of breast cancer. However, exposure to 
combination of anticancer drugs used in present study did 
not reveal any significant change in frequency of SA. 
From the foregoing discussion, it is concluded that higher 
frequency of hyperdiploid configuration remained 
unchanged in both treated as well as untreated breast cancer 
patients. In case of untreated lymphocytes of breast cancer 
patients, the possible cause of hyperdiploidy could be due to 
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genomic instability and/ or an exposure to environmental 
factors which includes carcinogens that may alter 
chromosome copy. The exact mechanism of action of 
chemotherapeutic treatment in peripheral blood 
lymphocytes of breast cancer patients is not fully 
understood with special reference to chromosomal 
rearrangements.                   
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